ATE481967T1 - Melanozyten-tyrosinasehemmer als aufheller von topischen hauttypen - Google Patents

Melanozyten-tyrosinasehemmer als aufheller von topischen hauttypen

Info

Publication number
ATE481967T1
ATE481967T1 AT07013932T AT07013932T ATE481967T1 AT E481967 T1 ATE481967 T1 AT E481967T1 AT 07013932 T AT07013932 T AT 07013932T AT 07013932 T AT07013932 T AT 07013932T AT E481967 T1 ATE481967 T1 AT E481967T1
Authority
AT
Austria
Prior art keywords
brightening
topical skin
skin
skin types
tyrosinase inhibitors
Prior art date
Application number
AT07013932T
Other languages
English (en)
Inventor
Thomas Dooley
Ernest Curto
Original Assignee
Mediquest Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediquest Therapeutics Inc filed Critical Mediquest Therapeutics Inc
Application granted granted Critical
Publication of ATE481967T1 publication Critical patent/ATE481967T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/411—Aromatic amines, i.e. where the amino group is directly linked to the aromatic nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT07013932T 2000-02-29 2001-02-28 Melanozyten-tyrosinasehemmer als aufheller von topischen hauttypen ATE481967T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18561000P 2000-02-29 2000-02-29

Publications (1)

Publication Number Publication Date
ATE481967T1 true ATE481967T1 (de) 2010-10-15

Family

ID=22681701

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01916293T ATE367157T1 (de) 2000-02-29 2001-02-28 Melanocyt-tyrosinase hemmer als topische hautdepigmentierende mittel
AT07013932T ATE481967T1 (de) 2000-02-29 2001-02-28 Melanozyten-tyrosinasehemmer als aufheller von topischen hauttypen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT01916293T ATE367157T1 (de) 2000-02-29 2001-02-28 Melanocyt-tyrosinase hemmer als topische hautdepigmentierende mittel

Country Status (8)

Country Link
US (5) US20020044914A1 (de)
EP (2) EP1857109B1 (de)
AT (2) ATE367157T1 (de)
AU (1) AU2001243334A1 (de)
CA (1) CA2401336C (de)
DE (2) DE60129420T2 (de)
ES (1) ES2352974T3 (de)
WO (1) WO2001064206A2 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2471953A1 (en) * 2001-12-28 2003-07-17 Mediquest Therapeutics, Inc. Hydroxamic acid and its derivatives as inhibitors of melanocyte tyrosinase for topical skin lighteners
FR2845599B1 (fr) * 2002-10-11 2005-01-07 Lmd Medicament comprenant une thiouree pour son utilisation en tant que depigmentant
DE10252772A1 (de) * 2002-11-13 2004-05-27 Beiersdorf Ag Verwendung von einem oder mehreren Diethyldithiocarbamaten zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter und trockener Haut
PL1701940T3 (pl) * 2003-12-23 2008-11-28 H Lundbeck As Pochodne 2-(1H-indolilosulfanylo)benzyloaminy jako SSRI
JP5128277B2 (ja) 2004-05-28 2013-01-23 ユニジェン・インコーポレーテッド 二核酵素の強力な阻害剤としてのジアリールアルカン類
AR052308A1 (es) * 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
FR2877672B1 (fr) * 2004-11-10 2007-04-13 Oreal Utilisation du ptu pour favoriser la culture in vitro de melanocytes, en particulier de melanocytes fortement pigmentes
FR2880022B1 (fr) * 2004-12-24 2007-08-24 Mayoly Spindler Soc Par Action Nouveaux derives de la n-hydroxy-n'-phenyluree et de la n-hydroxy-n'-phenylthiouree et leur utilisation comme inhibiteurs de la synthese de la melanine
DE102005022292A1 (de) * 2005-05-13 2006-11-16 Basf Ag Verwendung von Peroxidzersetzern in kosmetischen und pharmazeutischen Mitteln zur Behandlung der Haut
AR054393A1 (es) * 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
US7629473B2 (en) * 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
FR2890070A1 (fr) * 2005-08-31 2007-03-02 Galderma Res & Dev Nouveaux inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
WO2007039821A2 (en) * 2005-08-31 2007-04-12 Galderma Research & Development Novel inhibitors of tyrosinase, their method of preparation and their use in human medicine and in cosmetics
KR100788161B1 (ko) * 2006-01-06 2007-12-21 (주)아모레퍼시픽 벤즈이미다졸 아민 유도체 또는 아미노퀴놀린 유도체를 함유하는 피부 미백용 조성물
US20080070982A1 (en) * 2006-09-15 2008-03-20 Graham Timmins System and methods of melanoma prevention
KR101661608B1 (ko) * 2008-07-21 2016-09-30 유니젠, 인크. 일련의 피부-화이트닝(라이트닝) 화합물
EP2193779A1 (de) * 2008-12-05 2010-06-09 Cognis IP Management GmbH Hautbleichmittel
CN102378622A (zh) 2009-03-31 2012-03-14 株式会社资生堂 美白剂及使皮肤美白的美容方法
KR101246682B1 (ko) * 2010-02-23 2013-04-01 충북대학교 산학협력단 아릴티오우레아 유도체를 함유한 미백용 조성물
FR2958845B1 (fr) * 2010-04-16 2012-06-01 Clc Technologie Nouvelles compositions depigmentantes
US20110269852A1 (en) * 2010-04-30 2011-11-03 Hampton University Methods and mechanisms involving hyperpigmentation particularly for african american skin
US8476251B2 (en) * 2010-07-29 2013-07-02 Conopco, Inc. Skin care compositions comprising substituted diamines
US8293218B2 (en) 2010-07-29 2012-10-23 Conopco, Inc. Skin care compositions comprising substituted monoamines
WO2012129260A1 (en) 2011-03-24 2012-09-27 Unigen, Inc. Compounds and methods for preparation of diarylpropanes
US20130273183A1 (en) * 2012-04-13 2013-10-17 Eastman Chemical Company 2-Pyrimidine Thioesters and Thiocarbonates as Skin Brightening Agents
US20150174034A1 (en) 2013-03-13 2015-06-25 Avon Products, Inc. Tyrosinase inhibitors
US9364405B2 (en) 2013-03-13 2016-06-14 Avon Products, Inc. Tyrosinase inhibitors
WO2014186344A2 (en) 2013-05-13 2014-11-20 New York University Methods and agents for treating tyrosinase-positive albinism
US11168068B2 (en) 2016-07-18 2021-11-09 Janssen Pharmaceutica Nv Tau PET imaging ligands
CN109661224B (zh) 2016-09-06 2022-05-24 联合利华知识产权控股有限公司 用于降低细胞黑色素含量的化合物
CN109180587A (zh) * 2018-09-20 2019-01-11 五邑大学 一种吡唑类似物的新用途
EP4035651B1 (de) 2021-01-11 2024-11-27 Mesoestetic Pharma Group, S.L. Depigmentierende dermopharmazeutische oder kosmetische zusammensetzung und deren verwendung
KR102543627B1 (ko) * 2021-01-22 2023-06-20 한국과학기술연구원 디메틸페닐티오우레아를 포함하는 피부 미백용 조성물
KR20230145150A (ko) 2021-02-12 2023-10-17 시므라이즈 아게 과색소 침착의 예방 및 치료를 위한 약제 (medicament)
US12558302B2 (en) 2021-04-01 2026-02-24 Mesoestetic Pharma Group, S.L Tyrosinase-inhibiting molecules and dermopharmaceutical composition that includes them
WO2025071094A1 (ko) * 2023-09-26 2025-04-03 부산대학교 산학협력단 타이로시네이즈 저해 활성을 가지는 머캅토 작용기 화합물의 용도

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1205114B (it) * 1987-05-29 1989-03-15 Boehringer Biochemia Srl 2-selenometil-1,4-diidropiridine,procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
JPH05124925A (ja) * 1991-04-09 1993-05-21 Sansho Seiyaku Co Ltd メラニン生成抑制外用剤
JPH05124922A (ja) * 1991-04-09 1993-05-21 Sansho Seiyaku Co Ltd メラニン生成抑制外用剤
AU672021B2 (en) * 1992-07-15 1996-09-19 Governors Of The University Of Alberta, The Radioimagingm and Radiochemotherapy Phenolicthiotether Aminesand Acyl Derivatives Therefor
JP3545097B2 (ja) * 1995-04-19 2004-07-21 御木本製薬株式会社 皮膚用化粧品
JPH09323955A (ja) * 1996-06-03 1997-12-16 Kao Corp 安息香酸誘導体及びこれを含有する医薬
US6337320B1 (en) * 1996-10-11 2002-01-08 Thione International, Inc. Reparatives for ultraviolet radiation skin damage
JPH1121225A (ja) * 1997-06-27 1999-01-26 Tanabe Seiyaku Co Ltd 美白用成分およびこれを含有する美白用皮膚外用剤
FR2770522B1 (fr) * 1997-11-04 2000-03-10 Oreal Composes comportant un fragment iminophenol et leur utilisation en cosmetique

Also Published As

Publication number Publication date
US7718185B2 (en) 2010-05-18
EP1857109A3 (de) 2008-03-19
US7858105B2 (en) 2010-12-28
AU2001243334A1 (en) 2001-09-12
WO2001064206A2 (en) 2001-09-07
EP1267868A2 (de) 2003-01-02
US20050152859A1 (en) 2005-07-14
US20090023793A1 (en) 2009-01-22
DE60129420T2 (de) 2008-04-03
US20090023792A1 (en) 2009-01-22
WO2001064206A3 (en) 2002-08-29
EP1857109A2 (de) 2007-11-21
US20020044914A1 (en) 2002-04-18
CA2401336C (en) 2014-12-23
EP1267868B1 (de) 2007-07-18
EP1857109B1 (de) 2010-09-22
ES2352974T3 (es) 2011-02-24
DE60129420D1 (de) 2007-08-30
CA2401336A1 (en) 2001-09-07
DE60143135D1 (de) 2010-11-04
US20030219393A1 (en) 2003-11-27
ATE367157T1 (de) 2007-08-15

Similar Documents

Publication Publication Date Title
ATE481967T1 (de) Melanozyten-tyrosinasehemmer als aufheller von topischen hauttypen
Kameyama et al. Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo
Brenner et al. Modifying skin pigmentation–approaches through intrinsic biochemistry and exogenous agents
Draelos Skin lightening preparations and the hydroquinone controversy
Leyden et al. Natural options for the management of hyperpigmentation
Park et al. Signaling pathways mediating melanogenesis
FUNASAKA et al. Depigmenting Effect of α‐Tocopheryl Ferulate on Normal Human Melanocytes
Brar et al. A comprehensive review of the role of UV radiation in photoaging processes between different types of skin
Tada et al. Alleviation effect of arbutin on oxidative stress generated through tyrosinase reaction with L-tyrosine and L-DOPA
CN101631532A (zh) 抑制黑素原生成的化合物的组合及其在化妆品中和在皮肤病学中的应用
Oh et al. Superoxide dismutase 1 inhibits alpha-melanocyte stimulating hormone and ultraviolet B-induced melanogenesis in murine skin
Redmond et al. Melanocytes are selectively vulnerable to UVA-mediated bystander oxidative signaling
WO2003057184A3 (en) Hydroxamic acid and its derivatives as inhibitors of melanocyte tyrosinase for topical skin lighteners
Yoshimoto et al. Establishment of photoaging in vitro by repetitive UVA irradiation: Induction of characteristic markers of senescence and its prevention by PAPLAL with potent catalase activity
ES2753887T3 (es) Procedimientos útiles en el estudio o la modulación de la pigmentación de la piel o del cabello, extractos vegetales para una utilización en composiciones y procedimiento de cuidado cosmético
Park et al. Prevention of UV radiation‐induced premature skin aging in hairless mice by the novel compound melanocin A
Arbab et al. Review on skin whitening agents
박정일 et al. Tyrosinase inhibition activity of some herbal drugs
Song et al. The correlation of in vitro mushroom tyrosinase activity with cellular tyrosinase activity and melanin formation in melanoma cells A2058
ZA200109205B (en) Screening methods for compounds that affect melanogenesis.
Dan et al. Photobiomodulation Using 830 Nm Lighting‐Emitting Diode Inhibits Melanogenesis via FOXO3a in Human Melanocyte
da Cunha et al. Melasma: A review about pathophysiology and treatment
Singh et al. Photoaging
Radhakrishnan et al. Changing skin color: evolution and modern trends
Calzavara-Pinton et al. Pigmentation after solar radiation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties